Medexus Lists October 2018 Unsecured Convertible Debentures on the TSX Venture Exchange
February 12 2019 - 7:00AM
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.)
(the “Company”) (TSXV: MDP, OTCQB: PDDPF) today announced
that the 6.0% unsecured convertible debentures of the Company (the
“Debentures”) will commence trading on the TSX Venture Exchange
under the symbol “MDP.DB” at the market opening today, Tuesday,
February 12, 2019. The Debentures were issued on October 16, 2018
upon the automatic conversion of subscription receipts of the
Company which were issued pursuant to a private placement of the
Company on October 11, 2018.
About Medexus Pharmaceuticals
Inc.
Medexus Pharmaceuticals Inc. is a leading
specialty pharmaceutical company with a strong North American
commercial platform. The Company’s vision is to provide the best
healthcare products to healthcare professionals and patients,
through our core values of Quality, Innovation, Customer Service
and Teamwork. Medexus Pharmaceuticals is focused on the
therapeutic areas of auto-immune disease and pediatrics. The
leading products are Rasuvo and Metoject, a unique formulation of
methotrexate (auto-pen and pre-filled syringe) designed to treat
rheumatoid arthritis and other auto-immune diseases; and Rupall, an
innovative allergy medication with a unique mode of action.
For more information, please
contact:
Ken d’Entremont, Chief Executive OfficerMedexus
Pharmaceuticals Inc.Tel.: 905-676-0003E-mail:
ken.dentremont@medexusinc.com
Roland Boivin, Chief Financial OfficerMedexus
Pharmaceuticals Inc.Tel.: 514-762-2626 ext. 202E-mail:
roland.boivin@medexusinc.com
Investor Relations:Frank CandidoDirect
Financial Strategies and Communication Inc.Tel: 514-969-5530E-mail:
fcandi@medexusinc.com
Neither the TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release.
Medexus Pharmaceuticals (TSXV:MDP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Medexus Pharmaceuticals (TSXV:MDP)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Medexus Pharmaceuticals Inc (TSX Venture Exchange): 0 recent articles
More News Articles